SCHEMBL19032830

SCHEMBL19032830

N#Cc1ccccc1Cn1c(=O)c(-c2cc(I)ccc2N)nc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 5/20 0.51
▸ MAPK1 P28482 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 3/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ NOX4 Q9NPH5 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ ALOX5AP P20292 1/20 0.41
▸ CYP3A4 P08684 1/20 0.39
▸ DPP4 P27487 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19046558 0.88 CFTR (0.51) CFTRMAPK1MEN1KMT2ALMNA
SCHEMBL19032856 0.82 CFTR (0.62) CFTRMAPK1MEN1KMT2AMAPT
SCHEMBL19046529 0.82 CFTR (0.55) CFTRMAPK1MEN1KMT2AMAPT
SCHEMBL19032791 0.72 CFTR (0.57) CFTRMAPK1MEN1KMT2AHTT
SCHEMBL19046446 0.71 CFTR (0.62) CFTRMAPK1MEN1KMT2ALMNA
SCHEMBL19032808 0.71 CFTR (0.75) CFTRMAPK1MEN1KMT2AMAPT
SCHEMBL19046533 0.70 CFTR (0.55) CFTRMAPK1MEN1KMT2AMAPT
SCHEMBL24363056 0.70 CFTR (0.72) CFTRMAPK1MEN1KMT2AMAPT
SCHEMBL19032775 0.70 CFTR (0.72) CFTRMAPK1MEN1KMT2AMAPT
SCHEMBL19032803 0.70 CFTR (0.72) CFTRMAPK1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503447-B2 CFTR regulators and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-12-23 — — US disclosed
EP-4071140-B1 CFTR REGULATORS AND METHODS OF USE THEREOF UNIV CALIFORNIA (US) 2024-07-03 — — EP disclosed
EP-4071140-B1 CFTR REGULATORS AND METHODS OF USE THEREOF UNIV CALIFORNIA (US) 2024-07-03 — — EP disclosed
EP-4071140-A1 CFTR REGULATORS AND METHODS OF USE THEREOF The Regents of The University of California (US) 2022-10-12 — — EP disclosed
EP-4071140-A1 CFTR REGULATORS AND METHODS OF USE THEREOF The Regents of The University of California (US) 2022-10-12 — — EP disclosed
EP-3394046-B1 CFTR REGULATORS AND METHODS OF USE THEREOF UNIV CALIFORNIA (US) 2022-03-09 — — EP disclosed
US-20210347742-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-11-11 — — US disclosed
US-20210347742-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-11-11 — — US disclosed
US-11084795-B2 CFTR regulators and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-10 — — US disclosed
US-11084795-B2 CFTR regulators and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-10 — — US disclosed
CN-108699040-B Modulators of CFTR and methods of use thereof 加利福尼亚大学董事会 2021-08-10 — — CN disclosed
US-20190031622-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-01-31 — — US disclosed
US-20190031622-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-01-31 — — US disclosed
EP-3394046-A1 CFTR REGULATORS AND METHODS OF USE THEREOF The Regents of the University of California, A California Corporation (US) 2018-10-31 — — EP disclosed
WO-2017112950-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-06-29 — — WO disclosed
WO-2017112950-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190031622-A1 CFTR REGULATORS AND METHODS OF USE THEREOF CFTR, SLC26A4, CLCN2 CFTR 1/4885MAPK1 3851/4885MEN1 4526/4885
US-20210347742-A1 CFTR REGULATORS AND METHODS OF USE THEREOF CFTR, SLC26A4, CLCN2 CFTR 1/4885MAPK1 3851/4885MEN1 4526/4885
US-11084795-B2 CFTR regulators and methods of use thereof CFTR, SLC26A4, CLCN2 CFTR 1/4885MAPK1 3851/4885MEN1 4526/4885
US-12503447-B2 CFTR regulators and methods of use thereof CFTR, SLC26A4, CLCN2 CFTR 1/4885MAPK1 3851/4885MEN1 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback